Trial conduct and reference
Infection
INFECTION
The study was conducted at the Doherty Institute for Infection and Immunity in Melbourne, and at its partner Royal Melbourne Hospital, and was approved by the Royal Melbourne Hospital Human Research Ethics Committee.As an external reference, pre- and post-4th dose booster serum samples were evaluated from healthy adults boosted with Moderna Spikevax Omicron BA.1 bivalent vaccine as a subset of participants enrolled in another COVID booster clinical trial registered with The Australian/New Zealand clinical trials registry (ACTRN12622000411741) (